No photo of Raymond Bergan

View Scopus Profile

Raymond Bergan

Professor

  • 3969 Citations
  • 37 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Raymond Bergan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

SPORE in Prostate Cancer

Bergan, R., Jindan, Y., Kaul, K. L., Catalona, W., Jovanovic, B., Abdulkadir, S. A. & Szmulewitz, R.

National Institutes of Health

8/18/15 → 7/31/20

Project: Research project

    • Therapeutically targeting cancer cell motility

    Bergan, R.

    National Institutes of Health

    1/1/16 → 12/31/19

    Project: Research project

    • Genistein-mediated Regulation of Prostate Cancer Cell Motility

    Bergan, R.

    National Institutes of Health

    9/23/08 → 7/31/14

    Project: Research project

    • PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS

    Bergan, R. & Bergan, R.

    National Institutes of Health

    9/30/03 → 9/29/12

    Project: Research project

    Molecular Correlates of Soy in Humans

    Bergan, R.

    National Institutes of Health

    9/30/02 → 8/31/05

    Project: Research project

    • Research Output

    A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

    Graff, J. N., Beer, T. M., Alumkal, J. J., Slottke, R. E., Redmond, W. L., Thomas, G. V., Thompson, R. F., Wood, M. A., Koguchi, Y., Chen, Y., Latour, E., Bergan, R. C., Drake, C. G. & Moran, A. E., Jul 1 2020, In : Journal for immunotherapy of cancer. 8, 2

    Research output: Contribution to journal › Article

    Open Access

    • Genistein treatment duration effects biomarkers of cell motility in human prostate

    Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 2019, In : PloS one. 14, 3, e0214078.

    Research output: Contribution to journal › Article

    Open Access
    • 6 Scopus citations

    Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells

    Li, Y., Guo, Y., Feng, Z., Bergan, R., Li, B., Qin, Y., Zhao, L., Zhang, Z. & Shi, M., Aug 18 2019, In : Nutrition and Cancer. 71, 6, p. 1007-1018 12 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential (ESP) Charges

    Mishra, R. K., Deibler, K. K., Clutter, M. R., Vagadia, P. P., O'Connor, M., Schiltz, G. E., Bergan, R. & Scheidt, K. A., Jan 1 2019, (Accepted/In press) In : Journal of Chemical Information and Modeling.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization

    Thrivikraman, G., Athirasala, A., Gordon, R., Zhang, L., Bergan, R., Keene, D. R., Jones, J. M., Xie, H., Chen, Z., Tao, J., Wingender, B., Gower, L., Ferracane, J. & Bertassoni, L., Dec 1 2019, In : Nature communications. 10, 1, 3520.

    Research output: Contribution to journal › Article

    Open Access
    • 6 Scopus citations